secwatch.observer — SEC 8-K summary
======================================

Issuer:     PharmaCyte Biotech, Inc. (PMCB)
CIK:        0001157075
Form:       8-K
Filed at:   2025-04-24T23:59:59+00:00
Accession:  0001683168-25-002790
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

PharmaCyte Biotech annual meeting elects directors, ratifies auditor, approves exec compensation
--------------------------------------------------------------------------------

- Annual meeting held Apr 24, 2025; quorum of 3,222,988 shares (~46.92%) present.
- All five director nominees elected: Silverman, Schechter, Abecassis, Weinstein, Walker.
- CBIZ CPAs P.C. ratified as auditor for FY ending Apr 30, 2025 (for: 3,123,042; against: 72,371).
- Non-binding advisory vote approved executive compensation (for: 1,094,399; against: 113,815; abstain: 21,543).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157075/000168316825002790/0001683168-25-002790-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157075/000168316825002790/pharmacyte_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-002790

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer